Stray Dog

Palantir: new US civilian contracts, but political pressure grows

  • Mixed: Two new federal civilian contracts (HUD, DHS) open an anti-fraud foothold, but at about $42.5 million combined they are small.
  • Bad news: CNBC disclosed Trump's PLTR purchases; the White House says an outside manager runs the account and there is no evidence of insider dealing.
  • Bad news: The Australian activist campaign has widened from Westpac to AUSTRAC, and the NHS 2027 re-tender is drawing more European rivals.
Read the full notes

Two new federal civilian contracts (HUD anti-fraud, DHS SaaS) open a civilian anti-fraud and grant-oversight beachhead, but they are small and now politically exposed: CNBC disclosed Trump's PLTR purchases on 2 Sep and 9 Sep. In Australia the activist campaign has widened from Westpac to AUSTRAC. The NHS 2027 re-tender is drawing more European rivals (Celonis joins Drystone and Quantexa).

Key evidence

  • USAspending verified: on 16 Sep HUD awarded an AI grant intelligence platform (grant oversight, fraud detection, compliance automation) with a first-year obligation of $10.43 million and options running to September 2031 (the 5-year structure signals long-term platform deployment)
  • DHS Procurement Operations, 29 Sep: SaaS licence, $32.11 million, one-year term
  • Combined, about $42.5 million already booked in Q3, which is small relative to revenue
  • CNBC, 19 Nov: Trump's latest financial disclosure shows an account bought PLTR on 2 Sep and 9 Sep (combined bracket of $16,000 to $65,000), with contracts signed within 1-2 weeks. The White House says the account is independently managed by an external manager and there is no evidence of insider dealing. Political risk: the conflict-of-interest narrative feeds Wyden's oversight (he previously threatened compulsory process)
  • Capital Brief, 19 Nov: GetUp, after pushing Westpac not to renew, sent a letter on 6 Nov to the head of AUSTRAC (Australia's anti-money-laundering regulator) and Home Affairs Minister Burke, demanding that the Palantir contract be terminated and a public privacy impact assessment be carried out
  • The AUSTRAC head replied only that security and data controls are baseline requirements and did not signal termination
Show 5 more
  • The Guardian, 16 Nov, reported on the Criminal Intelligence Commission anti-fraud taskforce: Australian government business is shifting from isolated disputes to an organised campaign
  • No sign yet of a contract cancellation in Australia
  • City AM, 19 Nov: UK Parliament is to debate removing Palantir from NHS systems. Onwurah, chair of the House of Commons Science and Technology Committee, said that arguing break clauses are unrealistic now is itself proof of vendor lock-in, and demanded an immediate reduction in dependency
  • German process-mining firm Celonis publicly welcomed the 2027 re-tender being open to European suppliers. The competitor list is expanding (UK consortium Drystone and Quantexa are already in)
  • NHS contract about £330 million over 7 years, under 1% of revenue. The signal to watch is whether the sovereign replacement narrative spreads to other countries

Catalysts to watch

  • Wyden escalating oversight by leveraging the Trump disclosure optics (potential compulsory process)
  • AUSTRAC's response to the GetUp letter: any formal review would signal the Australia campaign is gaining traction
  • Outcome of the UK Parliament NHS debate
  • Competitor announcements for the 2027 NHS re-tender (Celonis, Drystone and Quantexa confirmed)
  • Other sovereign governments copying the NHS re-tender stance

Risks

  • The Trump disclosure gives ammunition to political oversight even without any evidence of insider dealing: a narrative risk independent of the facts
  • The Australia campaign is organised: GetUp is moving systematically from Westpac to AUSTRAC to the CIC taskforce
  • NHS vendor lock-in framing: Onwurah's statement turns Palantir's strength into a political liability
  • Celonis's entry signals the 2027 re-tender will be competitive, and the sovereign replacement narrative is replicating across the EU
  • Federal civilian contracts are small (under $50 million combined), so not yet a financial catalyst

Sources 7

  1. USAspending.gov raw records
  2. CNBC, 19 Nov, Trump disclosure
  3. Capital Brief, 19 Nov
  4. The Guardian, 16 Nov
  5. City AM, 19 Nov
  6. UK House of Commons Science and Technology Committee (Onwurah)
  7. Celonis public statement